Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Category 2

Growth Hormone

Ternary Complex Formation and IGFBP3 Proteolytic Activity During Childhood: Age-Dependent Changes
aErasmus MC – Sophia Children’s Hospital, Rotterdam, The Netherlands; bDutch Growth Research Foundation, Rotterdam, The Netherlands; cUniversity Medical Center Utrecht, Utrech, The Netherlands
hrp0082p2-d1-409
GHR Gene Variants within Coding and Intronic Regions in Children with Idiopathic Short Stature
Centro de Investigaciones Endocrinológicas ‘Dr César Bergadá’ (CEDIE) CONICET – FEI – División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
hrp0082p2-d1-410
Spontaneous Baseline GH Secretion Signalling as a Regulator of Bone Metabolism in Children
Gothenburg Pediatric Growth Research Center (GP-GRC), University of Gothenburg, Göteborg, Sweden
hrp0082p2-d1-411
ALS Deficiency due to a Novel and Two Already Described IGFALS Gene Mutations in an Unusual Non Consanguineous Family: Two Compound Heterozygous (Father and Son) and Two Heterozygous Carriers (Brother and Mother)
Centro de Investigaciones Endocrinológicas ‘Dr César Bergadá’ (CEDIE), CONICET – FEI – División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
hrp0082p2-d1-412
A Re-Evaluation of GH Secretion with Combined Test (GHRH+ARG/PD) in Children with Prader-Willi Syndrome
aAutoimmune Endocrine Disease Unit, Bambino Gesù Children’s Hospital, Rome, Italy; bEndocrinology Unit, Bambino Gesù Children’s Hospital, Rome, Italy; cItalian Auxological Institute Foundation, Piancavallo, Verbania, Italy
hrp0082p2-d1-413
Final Height SDS Gain of GH Treated Children with SHOX Deficiency Describing Observational and Clinical Trial Data
aMedical Department Lilly Diabetes, Neuilly-sur-Seine, France; bLilly Research Laboratories, Windlesham, UK; cUniversité Paris Diderot, Sorbonne Paris Cité, Service d’Endocrinologie Diabétologie Pédiatrique and INSERM U1141 – Président CMEL AP-HP Hôpital Universitaire Robert-Debré, Centre de Référence Maladies E, Paris, France
hrp0082p2-d1-414
IGF1 is Associated with a More Favourable Pattern of Body Composition in Obese Children
aD.P.U.O. ‘Bambino Gesù’ Children’s Hospital – ‘Tor Vergata’ University, Rome, Italy; bDepartment of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden
hrp0082p2-d1-415
Absence of GH Signaling Induces Hypothalamic Inflammation that is Reversed in Response to a High Fat Diet
aDepartment of Endocrinology and Pediatrics, Instituto de Investigación Sanitaria Princesa (IP), Centro de Investi, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain; bThe Edison Biotechnology Institute, Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Biomedical Sciences, Athens, Ohio, USA
hrp0082p2-d1-416
GH Stimulated Levels in Prader-Willi Syndrome During the Transition Period between Childhood and Adulthood
aItalian Auxological Institute, Verbania, Italy; bRegina Margherita Hospital, Turin, Italy; cS. Raffaele Hospital, Milan, Italy; dBambino Gesù Hospital, Palidoro-Rome, Italy; eCivic Hospital of Treviglio, Treviglio (BG), Italy; fUniversity of Modena and Reggio Emilia, Modena, Italy; gOasi Maria SS, Troina (EN), Italy; hUniversity of Insubria, Varese, Italy; iCasa Sollievo della Sofferenza, S. Giovanni Rotondo (FG), Italy
hrp0082p2-d1-417
Response to GH Treatment in Patients with Silver Russell Syndrome
Erasmus University Medical Centre, Rotterdam, The Netherlands
hrp0082p2-d1-418
Pubertal Development During GH Treatment with or without Additional GnRH Analogue Treatment in Short Children Born Small for Gestational Age
aDivision of Endocrinology, Department of Pediatrics, Erasmus MC Sophia, Rotterdam, The Netherlands; bDutch Growth Research Foundation, Rotterdam, The Netherlands
hrp0082p2-d1-419
S.c. Injections of a Reversible Albumin-Binding GH Derivative (NNC0195-0092) in Adult Subjects with GH Deficiency is Well Tolerated
1Global Development, Novo Nordisk, Soeborg, Denmark; 2Aarhus University Hospital, Aarhus, Denmark; 3Rigshospitalet University of Copenhagen, Copenhagen, Denmark; 4Odense University Hospita, Odense, Denmark; 5Karolinska University Hospital, Stockholm, Sweden
hrp0082p2-d1-420
The Effects of Delaying Puberty with GnRH Agonists in Patients with Idiopathic GH Deficiency
aUniversity of Cambridge, Cambridge, UK; bThe Saban Research Institute of Children’s Hospital, Los Angeles, USA; cPediatric Endocrinology Division, Children’s Hospital, University of Erlangen, Erlangen, Germany; dPfizer Inc., Endocrine Care, New York, New York, USA; ePfizer Inc., Endocrine Care, Sollentuna, Sweden
hrp0082p2-d1-421